No results for ‘’
SMS Pharmaceuticals Ltd
₹442.95
(7.06%)
Wed, 23 Sept 2026, 03:37 pm
Health Technology
Pharmaceuticals: Major
24.5KSMS Pharmaceuticals Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 68.07 | 68.07 | 68.07 | 66.26 | 66.26 |
| FII | 0.31 | 0.04 | 0.28 | 0.03 | 0.08 |
| DII | 3.02 | 3.21 | 2.88 | 3.03 | 2.43 |
| Public | 28.60 | 28.69 | 28.78 | 30.67 | 31.22 |
| Government | 0 | 0 | 0 | 0 | 0 |
SMS Pharmaceuticals Ltd Shareholding Pattern
The SMS Pharmaceuticals Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the SMS Pharmaceuticals Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
SMS Pharmaceuticals Ltd (NSE: SMSPHARMA, BSE: 532815) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the SMS Pharmaceuticals Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
SMS Pharmaceuticals Ltd Shareholding Pattern (Latest)
The latest SMS Pharmaceuticals Ltd shareholding for Mar 2026 is:
- Promoters: 68.07%
- FII: 0.31%
- DII: 3.02%
- Public: 28.60%
- Government: 0%
Promoter holding in SMS Pharmaceuticals Ltd remains stable, reflecting consistent long-term commitment.
SMS Pharmaceuticals Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in SMS Pharmaceuticals Ltd.
- Mar 2026: 68.07%
- Dec 2025: 68.07%
- Sept 2025: 68.07%
- Jun 2025: 66.26%
- Mar 2025: 66.26%
Promoter stake remains largely stable, showing consistent ownership structure.
SMS Pharmaceuticals Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward SMS Pharmaceuticals Ltd.
- Mar 2026: 0.31%
- Dec 2025: 0.04%
- Sept 2025: 0.28%
- Jun 2025: 0.03%
- Mar 2025: 0.08%
FII holding in SMS Pharmaceuticals Ltd has increased recently, indicating rising foreign investor interest.
SMS Pharmaceuticals Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Mar 2026: 3.02%
- Dec 2025: 3.21%
- Sept 2025: 2.88%
- Jun 2025: 3.03%
- Mar 2025: 2.43%
DII holdings remain stable, reflecting steady institutional participation.
SMS Pharmaceuticals Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Mar 2026: 28.60%
- Dec 2025: 28.69%
- Sept 2025: 28.78%
- Jun 2025: 30.67%
- Mar 2025: 31.22%
Public holding remains stable with consistent retail participation.
SMS Pharmaceuticals Ltd Government Holding
Government holding in SMS Pharmaceuticals Ltd currently stands at 0%.
SMS Pharmaceuticals Ltd operates without significant government ownership.
SMS Pharmaceuticals Ltd Shareholding Analysis Summary
The SMS Pharmaceuticals Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
SMS Pharmaceuticals Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.
Regular monitoring of the SMS Pharmaceuticals Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.